Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
49.27
+0.57 (1.17%)
At close: Jun 10, 2026, 4:00 PM EDT
48.48
-0.79 (-1.60%)
After-hours: Jun 10, 2026, 4:47 PM EDT
Kiniksa Pharmaceuticals International, Employees
Kiniksa Pharmaceuticals International, had 366 employees as of December 31, 2025. The number of employees increased by 51 or 16.19% compared to the previous year.
Employees
366
Change (1Y)
51
Growth (1Y)
16.19%
Revenue / Employee
$2,060,232
Profits / Employee
$199,612
Market Cap
3.79B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 366 | 51 | 16.19% | 366 | 0 |
| Dec 31, 2024 | 315 | 18 | 6.06% | 315 | 0 |
| Dec 31, 2023 | 297 | 77 | 35.00% | 297 | 0 |
| Dec 31, 2022 | 220 | 5 | 2.33% | 220 | 0 |
| Dec 31, 2021 | 215 | 47 | 27.98% | 215 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,796 |
| Lantheus Holdings | 1,193 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
KNSA News
- 1 day ago - Kiniksa Pharmaceuticals International, Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 7 days ago - Kiniksa Pharmaceuticals International, Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Kiniksa price target raised to $64 from $62 at Canaccord - TheFly
- 6 weeks ago - Kiniksa price target raised to $59 from $58 at Wedbush - TheFly
- 6 weeks ago - Kiniksa price target raised to $60 from $50 at Citi - TheFly
- 6 weeks ago - Kiniksa price target raised to $71 from $58 at Jefferies - TheFly
- 6 weeks ago - Kiniksa rises 19.3% - TheFly